Magda Feres
The Global Prevention Symposium: Charting the Future of Oral Health and Medicine will bring together leading clinicians, researchers, educators, students, public health experts, and industry innovators to explore how prevention can transform healthcare and improve health outcomes across populations.
As healthcare systems increasingly shift from treatment to prevention, advances in early detection, precision diagnostics, artificial intelligence, and oral-systemic health are creating new opportunities to reduce disease burden and improve quality of life. Through expert presentations and interdisciplinary discussion, participants will examine emerging research, innovative technologies, and collaborative approaches that support earlier diagnosis, more effective intervention, and improved patient care.
Designed to foster collaboration across medicine, dentistry, public health, and industry, the symposium will connect leaders working to advance prevention science and translate innovation into real-world impact.
Participants will gain insights into:
The symposium will feature internationally recognized leaders in medicine, public health, diagnostics, oral health, and healthcare innovation.
Dr. David R. Walt is the Hansjörg Wyss Professor of Bioinspired Engineering at Harvard Medical School, professor of pathology at Harvard Medical School and Brigham and Women's Hospital, an associate member of the Broad Institute, and a Howard Hughes Medical Institute professor.
Walt is the scientific founder of Illumina and Quanterix and has co-founded several life sciences companies, including Ultivue, Arbor Biotechnologies, Sherlock Biosciences, Vizgen, and Protillion Biosciences. His research has advanced the fields of optical microwell arrays and single-molecule detection, leading to numerous scientific and clinical applications.
He has received many national and international honors, including the Kabiller Prize in Nanoscience and Nanomedicine and the National Academy of Engineering's Fritz J. and Dolores H. Russ Prize. Walt is a member of the National Academy of Engineering, the National Academy of Medicine, and the American Philosophical Society, and a fellow of the American Academy of Arts and Sciences, the American Institute for Medical and Biological Engineering, the American Association for the Advancement of Science, and the National Academy of Inventors. He is also an inductee of the National Inventors Hall of Fame.
In 2025, Walt received the National Medal of Technology and Innovation from President Joe Biden.
Dr. Rifat Atun is the dean of education and innovation at the Harvard T.H. Chan School of Public Health. He is the Julio Frenk Professor of Public Health Leadership, professor of global health systems and director of the Health Systems Innovation Lab at Harvard University.
Atun is a faculty affiliate at the Center for International Development at the Harvard Kennedy School and serves on the Harvard University Asia Center Steering Committee and Council. He is also a visiting professor at Imperial College London and a distinguished visiting professor at Fukushima University in Japan.
Before joining Harvard, Atun was professor of international health management and head of the Health Management Group at Imperial College London. From 2008 to 2012, he served on the executive management team of the Global Fund to Fight AIDS, Tuberculosis and Malaria, where he led strategy, performance, and evaluation and helped oversee multibillion-dollar global health investments across more than 120 countries.
Atun has advised governments, international organizations, and leading companies on health systems, innovation, strategy, and leadership. He has designed and led executive education programs and undertaken assignments for organizations including Novartis, Medtronic, GSK, AbbVie, Merck, Pfizer, Vodafone, Roche, BCG, and Kearney.
Additional speakers and program details will be announced as they are confirmed
A detailed symposium schedule, including session times and speaker information, will be available soon.
Select the registration category that best applies to you.
| Registration category | Fee |
|---|---|
Students | Complimentary with a valid .edu email address |
Faculty and educators at HSDM or from other academic institutions | Complimentary with a valid .edu email address |
General attendees | $150 |
Corporate and industry attendees | $300 |
Virtual attendess | $50 |
The Harvard School of Dental Medicine Prevention Initiative advances a prevention-first approach to oral healthcare through education, research, and interdisciplinary collaboration. Established through the generosity of Dr. Paul A. Levi Jr. and Patty Levi, the initiative equips current and future oral healthcare professionals with the knowledge and skills to prevent disease, promote early detection, and improve patient outcomes. Through distinguished lectures, educational programs, and symposiums, HSDM convenes leaders in dentistry, medicine, public health, and industry to advance prevention science and translate research into clinical practice.
Learn more about the inspiration behind the Prevention Initiative to discover how HSDM is advancing prevention through education, research, and collaboration.